Heska Corporation NASDAQ:HSKA

Financial Health
0
1
2
3
4
5
6
7
8
9

Heska stock price monthly change

-1.21%
month

Heska stock price quarterly change

+43.54%
quarter

Heska stock price yearly change

+20.38%
year

Heska key metrics

Market Cap
1.30B
Enterprise value
1.16B
P/E
-60.79
EV/Sales
4.52
EV/EBITDA
-208.17
Price/Sales
4.73
Price/Book
2.88
PEG ratio
0.03
EPS
-1.78
Revenue
254.88M
EBITDA
-14.83M
Income
-18.59M
Revenue Q/Q
-3.73%
Revenue Y/Y
-1.21%
Profit margin
-7.73%
Oper. margin
-7.89%
Gross margin
43.2%
EBIT margin
-7.89%
EBITDA margin
-5.82%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Heska stock price history

Heska stock forecast

Heska financial statements

Heska Corporation (NASDAQ:HSKA): Profit margin
Jun 2022 64.67M -4.89M -7.56%
Sep 2022 61.49M -78K -0.13%
Dec 2022 66.33M -3.85M -5.8%
Mar 2023 62.38M -9.77M -15.67%
Heska Corporation (NASDAQ:HSKA): Debt to assets
Jun 2022 586789000 169.50M 28.89%
Sep 2022 570067000 162.16M 28.45%
Dec 2022 585816000 163.60M 27.93%
Mar 2023 592715000 175.04M 29.53%
Heska Corporation (NASDAQ:HSKA): Cash Flow
Jun 2022 1.05M -759K 391K
Sep 2022 -2.03M -4.65M -2.05M
Dec 2022 -3.16M -514K -2.12M
Mar 2023 -9.16M -22.55M -128K

Heska alternative data

Heska Corporation (NASDAQ:HSKA): Employee count
Aug 2023 808
Sep 2023 808
Oct 2023 808
Nov 2023 808
Dec 2023 808
Jan 2024 808
Feb 2024 808
Mar 2024 808
Apr 2024 808
May 2024 808
Jun 2024 808
Jul 2024 808

Heska other data

89.13% -10.87%
of HSKA is owned by hedge funds
9.22M -1.28M
shares is hold by hedge funds

Heska Corporation (NASDAQ:HSKA): Insider trades (number of shares)
Period Buy Sel
Mar 2022 0 663
Dec 2022 3440 0
Jan 2023 11018 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
WILSON KEVIN S. director, officer: CEO and Pres..
Common Stock 5,365 $59.05 $316,809
Purchase
WILSON KEVIN S. director, officer: CEO and Pres..
Common Stock 5,653 $58.22 $329,118
Purchase
WILSON KEVIN S. director, officer: CEO and Pres..
Common Stock 240 $59.57 $14,297
Purchase
WILSON KEVIN S. director, officer: CEO and Pres..
Common Stock 796 $59.62 $47,458
Purchase
WILSON KEVIN S. director, officer: CEO and Pres..
Common Stock 105 $59.64 $6,262
Purchase
WILSON KEVIN S. director, officer: CEO and Pres..
Common Stock 2,299 $59.65 $137,135
Option
WISNEWSKI NANCY officer: Chief Op.. Incentive Stock Option (right to buy) 10,000 $8.55 $85,500
Option
WISNEWSKI NANCY officer: Chief Op.. Common Stock 10,000 $8.55 $85,500
Option
WISNEWSKI NANCY officer: Chief Op.. Performance Shares 1,562 N/A N/A
Option
WISNEWSKI NANCY officer: Chief Op.. Common Stock 1,562 N/A N/A
Tuesday, 23 May 2023
businesswire.com
Wednesday, 10 May 2023
businesswire.com
Friday, 5 May 2023
Zacks Investment Research
Monday, 3 April 2023
The Motley Fool
Tuesday, 28 February 2023
Seeking Alpha
Zacks Investment Research
Monday, 13 February 2023
Zacks Investment Research
Thursday, 12 January 2023
GuruFocus
Wednesday, 11 January 2023
Zacks Investment Research
Saturday, 12 November 2022
Seeking Alpha
Monday, 8 August 2022
Seeking Alpha
Zacks Investment Research
Monday, 9 May 2022
Seeking Alpha
Zacks Investment Research
Tuesday, 29 March 2022
Proactive Investors
Monday, 28 February 2022
Seeking Alpha
Zacks Investment Research
Thursday, 24 February 2022
Zacks Investment Research
Monday, 21 February 2022
Zacks Investment Research
Saturday, 6 November 2021
Seeking Alpha
Monday, 1 November 2021
InvestorPlace
Monday, 25 October 2021
Invezz
  • When is Heska's next earnings date?

    Unfortunately, Heska's (HSKA) next earnings date is currently unknown.

  • Does Heska pay dividends?

    No, Heska does not pay dividends.

  • How much money does Heska make?

    Heska has a market capitalization of 1.30B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.41% to 257.31M US dollars.

  • What is Heska's stock symbol?

    Heska Corporation is traded on the NASDAQ under the ticker symbol "HSKA".

  • What is Heska's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Heska?

    Shares of Heska can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Heska's key executives?

    Heska's management team includes the following people:

    • Mr. Kevin S. Wilson Chief Executive Officer, Pres & Director(age: 53, pay: $1,110,000)
    • Ms. Catherine I. Grassman CPA Executive Vice President & Chief Financial Officer(age: 49, pay: $544,530)
    • Mr. Steven M. Eyl Executive Vice President, Chief Commercial Officer & Pres of scil animal care company(age: 59, pay: $521,340)
    • Dr. Nancy Wisnewski Executive Vice President & Chief Operating Officer(age: 62, pay: $474,300)
  • How many employees does Heska have?

    As Jul 2024, Heska employs 808 workers.

  • When Heska went public?

    Heska Corporation is publicly traded company for more then 28 years since IPO on 1 Jul 1997.

  • What is Heska's official website?

    The official website for Heska is heska.com.

  • Where are Heska's headquarters?

    Heska is headquartered at 3760 Rocky Mountain Avenue, Loveland, CO.

  • How can i contact Heska?

    Heska's mailing address is 3760 Rocky Mountain Avenue, Loveland, CO and company can be reached via phone at +970 4937272.

Heska company profile:

Heska Corporation

heska.com
Exchange:

NASDAQ

Full time employees:

808

Industry:

Medical - Devices

Sector:

Healthcare

Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.

3760 Rocky Mountain Avenue
Loveland, CO 80538

CIK: 0001038133
ISIN: US42805E3062
CUSIP: 42805E306